在胰腺癌中超越阿片类药物:缓解性放射治疗和腹腔复合放射手术
Marcin Miszczyk1, Ross A Abrams2, Yaacov R Lawrence3
1Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria; Collegium Medicum - Faculty of Medicine, WSB University, Dąbrowa Górnicza, Poland.
Seminars in radiation oncology
|September 11, 2025
概括
放射治疗有效地管理胰腺癌症状,在全身治疗不足时提供局部症状控制. 诸如立体性身体辐射疗法 (SBRT) 和乳结核放射性手术等技术在息治疗中显示出有前途.
科学领域:
- 在瘤学瘤学.
- 抚慰性护理是一种缓解性护理.
- 辐射瘤学 辐射瘤学
背景情况:
- 胰腺癌通常表现为晚期疾病和有限的预期寿命.
- 患者经常会因为这种疾病而经历多种衰弱症状.
- 系统疗法对局部疾病症状的疗效有限.
研究的目的:
- 审查已建立和新兴的放射治疗方法,以缓解胰腺癌的治疗.
- 评估放射治疗在多学科患者护理中的作用.
- 为了比较不同辐射技术对症状控制的有效性.
主要方法:
- 审查已建立和不断发展的放射治疗技术.
- 对立体性身体辐射疗法 (SBRT) 的评估.
- 评估乳结质放射性手术的有效性.
主要成果:
- 放射治疗在胰腺癌的局部症状控制中是有效的.
- 低分离辐射疗法在多学科管理中起着至关重要的作用.
- 立体性身体辐射疗法 (SBRT) 和乳结核放射性手术是关键的方法.
结论:
- 放射治疗是胰腺癌患者的息治疗的一个被低估但至关重要的组成部分.
- 有效的患者-提供者沟通和早期的息护理整合是必不可少的.
- 辐射疗法为症状管理提供了显著的好处,包括转移性疾病.
相关概念视频
Chronic Pancreatitis II: Collaborative Care
317
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
317
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K


